EGR1 and colorectal carcinoma: In the case of CRC patients, ROC analyses proved that our 7‐lncRNA‐based panel enables to distinguish those samples from HCs with a sensitivity of 74% and specificity of 70% with an AUC = 0.7879 (Fig. S7C, Table S9A), while the improved panel augmented by EGR1 enabled to distinguish these two cohorts with a sensitivity of 78% and specificity of 78% with AUC = 0.8522 (Fig. 4C, Table S9B).